Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...
Gilead Withdraws Bladder Cancer Drug in US After Failed Trial
(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of ...
Reuters3d
Gilead withdraws bladder cancer drug in US after failed trial
Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...
Reuters18d
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Oct 2 (Reuters) - Gilead Sciences (GILD.O ... In the U.S., the drug is approved for multi-drug resistant HIV and sold under the brand "Sunlenca" for an annual list price of $42,250 per year.